# The Efficacy of Using Pentoxifylline in Patients Undergoing Breast Cancer Surgery

> **NCT06087237** · PHASE2 · COMPLETED · sponsor: **Mansoura University** · enrollment: 92 (actual)

## Conditions studied

- Post-Surgical Complication
- Breast Cancer Surgery

## Interventions

- **DRUG:** Pentoxifylline
- **DRUG:** paracetamol +ketorolac

## Key facts

- **NCT ID:** NCT06087237
- **Lead sponsor:** Mansoura University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-30
- **Primary completion:** 2024-06-30
- **Final completion:** 2024-06-30
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2025-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06087237

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06087237, "The Efficacy of Using Pentoxifylline in Patients Undergoing Breast Cancer Surgery". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06087237. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*